Page last updated: 2024-10-27

fenoldopam and Cancer of Kidney

fenoldopam has been researched along with Cancer of Kidney in 2 studies

Fenoldopam: A dopamine D1 receptor agonist that is used as an antihypertensive agent. It lowers blood pressure through arteriolar vasodilation.

Research Excerpts

ExcerptRelevanceReference
"Fenoldopam is a short-acting dopamine-1 receptor agonist that might provide renal protection during ischemic stress."2.78Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial. ( Bonilla, AM; Campbell, SC; Fergany, AF; Gill, IS; Kaouk, JH; Kaple, KM; Mahboobi, R; Mascha, EJ; Novak, SM; O'Hara, JF; Sessler, DI; Ziegman, SA, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
O'Hara, JF1
Mahboobi, R1
Novak, SM1
Bonilla, AM1
Mascha, EJ1
Fergany, AF1
Campbell, SC1
Kaouk, JH1
Kaple, KM1
Gill, IS1
Ziegman, SA1
Sessler, DI1
Huang, WC1

Trials

1 trial available for fenoldopam and Cancer of Kidney

ArticleYear
Fenoldopam and renal function after partial nephrectomy in a solitary kidney: a randomized, blinded trial.
    Urology, 2013, Volume: 81, Issue:2

    Topics: Acute Kidney Injury; Aged; Carcinoma, Renal Cell; Creatinine; Dopamine Agonists; Double-Blind Method

2013

Other Studies

1 other study available for fenoldopam and Cancer of Kidney

ArticleYear
Editorial comment.
    Urology, 2013, Volume: 81, Issue:2

    Topics: Acute Kidney Injury; Carcinoma, Renal Cell; Dopamine Agonists; Female; Fenoldopam; Glomerular Filtra

2013